Articles tagged with Brain Damage
Researchers have developed a novel platform for testing radiation therapy effects on brain cells, providing insights into how the brain reacts to cancer treatment. The study aims to improve treatment strategies by understanding the impact of radiation on neural circuits, ultimately leading to personalized care for patients.
Researchers at the Plasticity and Remodeling of Neural Circuits laboratory aim to stimulate myelin plasticity to regenerate affected nerve fibers in MS patients. The team will explore gene therapy, pharmacological approaches, and rehabilitation strategies to enhance myelin repair.
A study published in Nature Communications found that one in eight newborn babies has a genetic protection against jaundice. The researchers identified a specific gene variant that codes for an enzyme linked to increased bilirubin metabolism, providing an opportunity for personalized medicine.
A Trinity scientist has won an ERC Starting Grant to investigate the role of microglia in brain disorders. The project aims to create a detailed map of how these immune cells change during brain damage, disease, or repair, with the goal of developing methods to control and rejuvenate neuropathology.
Researchers will combine stem cell therapy with brain-computer interfaces to restore function to patients with brain damage. The goal is to create bidirectional connections between cultured brain cells and the living human brain.
A new study reveals that more than half of strokes causing ataxia are located outside the cerebellum but affect a specific brain network. This discovery changes our understanding of ataxia's neural mechanisms and may lead to safer treatments for patients.
A study led by Prof. Seo Byeong-Chang has discovered the working principle of proton-activated chloride (PAC) channels, which play a crucial role in protecting cells from acidification-induced damage. The research found that PI(4,5)P2 is essential for activating PAC channels, preventing cell swelling and tissue damage.
A study by Baylor College of Medicine researchers reveals that Tau protein mitigates neuronal damage caused by reactive oxygen species and promotes healthy aging. The findings support a new neuroprotective role for Tau against the toxicity associated with ROS.
A new $3.5 million NIH grant will investigate the complex interplay between traumatic brain injury and genetic risk factors in the development of Alzheimer's disease. The three-year study will use rodents to assess disease progression across different age periods, providing insights into potential early intervention strategies.
Researchers at Karolinska Institutet have conducted a Phase 2 UNITY clinical trial involving pregnant women with a history of very severe HDFN. Nipocalimab was found to prevent and mitigate the disease without causing serious side effects in the mother or fetus.
Viji Santhakumar, a UCR professor, has been awarded a $3.5 million NIH grant to study brain circuit function and its impact on memory formation and cognitive deficits in diseases like epilepsy and Alzheimer's disease.
Scientists at The Hospital for Sick Children discovered a molecule called LK-2 that can protect neurons during stroke and prevent brain damage. LK-2 works by blocking glutamate's binding to acid-sensing ion channels, reducing calcium flow and cell death.
The West Virginia University athletic training researcher developed a new national position statement on emergency action plan development and implementation in sports. The recommendations aim to reduce catastrophic injuries by designating an emergency action plan coordinator who collaborates with other athletic staff.
A middle-aged man suffered from toxic leukoencephalopathy after fentanyl inhalation, leading to inflammation and damage to white matter in the brain. Despite prolonged hospitalization, he eventually recovered with rehabilitation therapy.
Researchers at Gladstone Institutes have identified a blood coagulation protein, fibrin, as the culprit behind toxic inflammation and neuron loss after a major head injury. This finding can inform new treatment strategies for traumatic brain injuries, which often lead to dementia, depression, and difficulty concentrating.
A new study has identified the likely origin of tone deafness in the brain, finding that strokes causing amusia affect the right hemisphere and a specific region called the superior temporal gyrus. This discovery highlights the differences between processing music and language in the brain, with implications for diagnosis and treatment.
The themed issue highlights advances in nosology, covert consciousness assessment, neuromedical morbidity, neurorehabilitation evaluation, and medicolegal challenges. Patients with severe brain injuries may have better prognoses than previously believed, but require careful assessment due to high misdiagnosis rates.
A new study published in eClinicalMedicine found that the iTalkBetter app significantly improved patients' ability to talk after six weeks of use. The app provided digital speech therapy for over 200 commonly used words, with a 13% increase in naming items and improvements in spontaneous speech.
A new blood test uses the biomarker BD-tau to predict functional outcomes in patients after ischemic stroke. Higher levels of BD-tau are associated with more severe outcomes.
Researchers found that baseline amyloid burden and brain health are stronger predictors of Alzheimer's progression than age alone. The study also showed that individuals with higher amyloid levels developed dementia two years earlier than those without.
Researchers have found that lowering a form of brain cholesterol known as cholesteryl esters helps prevent brain damage and behavioral changes in mice with Alzheimer's-like tau deposits. The study suggests that reducing cholesteryl ester levels could be a promising candidate to test in neurodegenerative diseases.
A recent study by the University of Gothenburg found no correlation between post-COVID condition and ongoing viral infection or active brain damage. The study analyzed 25 participants with confirmed post-COVID condition, six without residual symptoms, and 17 control subjects, revealing undetectable SARS-CoV-2 antigens in all samples.
A new study published in JAMA Neurology found that over 40% of young contact and collision sport athletes have CTE, a degenerative brain disease caused by repetitive head impacts. The study also highlighted the importance of assessing symptoms and clinical presentation of CTE in living athletes.
A team of New Jersey researchers reviewed the evidence on robotic exoskeleton devices for individuals with acquired brain injury, laying out a systematic framework for future research. The review highlights the need for comprehensive approaches to evaluate these devices and their role in improving mobility in individuals with acquired ...
Researchers discovered that continuous consumption of secondary microplastics acts as neurotoxins in the brain, leading to increased inflammation and cell death. The study found that artificially generated secondary microplastics from plastic leaked into the environment trigger severe brain inflammation in rats.
A pilot study suggests that high-definition cathodal transcranial direct current stimulation (HD C-tDCS) may be beneficial for acute ischemic stroke patients. In the study, patients who received HD C-tDCS showed improved blood flow and a significant rescue of threatened brain tissue, compared to those in the sham group.
A new study found that football players' cumulative repetitive head impact exposure was associated with chronic traumatic encephalopathy (CTE) status and severity. The study suggests that reducing both the number of head impacts and their force could lower CTE risk.
A new study published in The Neuroradiology Journal introduces an artificial intelligence computer program that can accurately identify changes in brain structure resulting from repeated head injury. This AI tool uses machine learning to process magnetic resonance imaging (MRI) scans and distinguish between the brains of male athletes ...
A University of Gothenburg study found that individuals who engaged in regular physical activity had smaller hemorrhages upon arrival at the hospital. Physically active patients experienced 50% less bleeding volume compared to inactive ones.
Researchers at UVA Health System have made a breakthrough discovery about the role of microglia in seizure disorders. The study suggests that enhancing microglial activity could be a promising approach to preventing and managing seizures, offering new hope for patients who don't respond to existing treatments.
A new study published in Neurology shows that younger brain age is associated with superior post-stroke outcomes, suggesting a potential biomarker for stroke rehabilitation. The research team used multi-site data sets and 3D brain structural MRIs to analyze the relationship between brain age and stroke recovery.
A study by Washington University School of Medicine suggests targeting T cells to prevent neurodegeneration and treat Alzheimer's disease. The research indicates that microglia partner with T cells to cause brain damage in the disease, and blocking their entry can avoid most neurodegeneration.
Researchers at Hokkaido University used hydrogel materials in combination with neural stem cells to grow new brain tissue in areas of brain damage. The study showed that immune cells and blood vessels grew within the hydrogels, leading to some degree of integration between the hydrogel and host brain tissue.
A study of over 350 patients with small vessel stroke found that the medications were well-tolerated and safe, suggesting potential benefits in improving patient outcomes. The results indicate that cilostazol and isosorbide mononitrate may help reduce recurrent stroke, cognitive impairment, and improve quality of life.
Researchers developed a CSIC vaccine that fully protects against SARS-CoV-2 infection in the brain and prevents associated brain damage. The MVA-CoV2-S vaccine candidate demonstrates sterilizing immunity and was effective even after reinfection with the virus.
A recent study from the University of Eastern Finland suggests that previous traumatic brain injury may increase the risk of frontotemporal dementia (FTD), particularly in individuals without a genetic mutation. Patients who suffered head injuries developed FTD earlier than others, on average.
A study by DGIST researchers identified the molecular mechanism behind PIP2's regulation of CaV2.2 channels, which play a crucial role in signal transmission between nerve cells. The findings offer new insights into treating mental disorders and neurological diseases such as autism, bipolar disorder, and chronic pain.
A study funded by NIH found that people with Down syndrome have a similar level of amyloid plaques in their brains as those with hereditary, early-onset Alzheimer's. This suggests that individuals with both conditions may benefit from participating in studies on Alzheimer's therapies aimed at slowing amyloid plaque formation.
A new study published in the journal Nature has identified medin as a key player in Alzheimer's therapies. Medin, a protein that accumulates in the blood vessels of the brain, promotes vascular pathology and cognitive decline. The researchers hope to develop a treatment targeting medin to prevent vascular damage and cognitive decline.
The FDA approved Aduhelm for Alzheimer's treatment based on reduced amyloid levels in the brain, despite no significant clinical effect. The use of amyloid-PET scans is being questioned for its accuracy and reliability in measuring amyloid removal.
Researchers at Washington University School of Medicine studied 350 people to understand how Alzheimer's disease affects the brain. The study found that gene APOE is active in the areas most damaged by the disease, leading to symptoms like language and vision problems.
Researchers suggest special blood vessels called 'retia mirabilia' reduce brain pressure pulses, preventing damage. Computer modeling supports theory, which could be applied to other animals and humans.
The new guidance provides a comprehensive approach to preventing unrecognised oesophageal intubation, addressing both technical and human factors. It recommends standardising carbon dioxide monitoring and pulse oximetry, using videolaryngoscopes for correct placement, and addressing stress-related management of crises.
A novel subset of CD8+ regulatory-like T cells (CD8+TRLs) has been identified as 'first responders' to stroke, providing fast-acting and lasting protection. These cells reach the brain within 24 hours after stroke onset, releasing molecules that provide direct neuroprotective effects.
Researchers have created a new mouse model that mimics brain damage caused by severe RVFV infection, enabling the study of disease mechanisms and high-throughput testing of next-generation drugs. This breakthrough has significant implications for developing therapies and vaccines for this devastating virus.
A recent study suggests that concussion symptoms in children may be caused by multiple types of brain damage, leading to varying sets of symptoms. The research found complex relationships between brain damage and symptoms, which could lead to improved treatments for individual patients.
A new study by McGill University researchers has shed light on the complex relationships between concussion symptoms and brain damage in children. The findings suggest that certain combinations of brain injury can lead to specific symptoms, such as attention difficulties and sleep problems.
Researchers discovered a link between traumatic brain injuries and changes in the gut microbiome, suggesting a potential diagnostic tool for concussions. The study found two bacterial species that dropped significantly after concussions, indicating a correlation with traumatic brain injury-linked proteins in the blood.
A study published in the Journal of Alzheimer's Disease Reports suggests that damage to the blood-brain barrier is the determining cause of Alzheimer's disease. The Lipid Invasion Model proposes that lipids entering the brain due to barrier damage lead to brain shrinkage, amyloid plaques, and tau tangles, characteristic of the disease.
Research from the University of Waterloo and the University of Auckland found that stabilizing blood sugar levels in newborns with hypoglycemia prevents brain damage. Untreated low blood sugar can cause adverse effects on a child's neurodevelopment up to age 4.5 years old.
Researchers found a strong connection between retinal layer thickness and brain volume, suggesting retina assessments as a potential biomarker for brain atrophy. Thinner retinal layers correlated with reduced brain white matter and hippocampus volume.
Scientists demonstrate a definitive link between mitochondrial oxidative damage and cognitive dysfunction in Alzheimer's disease using a transgenic mouse model. The study found that Aβ1-42 aggregation in the hippocampus caused cognitive impairment, while oxidation led to mitochondrial dysfunction.
A new study from the University of Illinois reveals that nearly all soil samples in Chicago contain high levels of lead, with some areas reaching up to 3,000 ppm. The findings highlight the need for further monitoring and mitigation efforts to address environmental justice concerns.
A ketogenic diet has been shown to improve spatial memory and visual memory, lower brain inflammation indices, and cause less neuronal death in individuals with traumatic brain injuries. The diet may also slow down the rate of cellular aging, offering hope for those suffering from this condition.
A long-term study found that academic education can positively affect aging of the brain, with reduced degenerative processes and improved cognitive performance. Participants with an academic background showed a lower increase in signs of brain degeneration and faster processing speeds.
Researchers have designed a digital camera-based system that can accurately detect jaundice in newborns within one second, sending diagnoses to carers via SMS. The system uses image processing techniques to detect bilirubin levels, triggering blue LED phototherapy and treatment.
A study published in JAMA Neurology found that long-term exposure to space can cause brain damage in cosmonauts. The research analyzed five Russian male cosmonauts who spent an average of 169 days in space, showing significant increases in biomarkers for brain cell damage upon their return to Earth.
A widely used procedure to treat birth-related brain damage in newborn babies in low and middle income countries (LMICs) may increase the risk of death. The HELIX trial found that 50% of infants who received the cooling treatment died or had moderate or severe disability.
A new protein marker, neurofilament light protein (NFL), has been found to predict stroke severity and long-term outcomes. The levels of NFL in blood correlate with more severe brain damage and poorer survival rates after stroke.
Heidelberg researchers demonstrate that restoring VEGFD levels can preserve dendritic arborisation and reduce brain damage after a stroke. A treatment using recombinant VEGFD and nose drops achieved similar results in mouse models.